NASDAQ:MEIP
Delisted

Mei Pharma Stock Signals

etoro logo Buy MEIP
*Your capital is at risk
$3.07
+0 (+0%)
At Close: Dec 09, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for MEI Pharma

General

Signal Type Signal Value Data
Score 0.000 62 days ( 0 %
Last Price $3.07 0 %
Performance History
7 Days
$3.07 $3.07
0%
30 Days
$3.07 $3.07
0%
12 Mos
$2.80 $3.07
9.64%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 64.19
Signal Type Signal Value Importance Data
High / Low N/A Very Low $3.07 - $3.07
Trend - 3 mos 0 % High Width: 0.00000000000029 %
Pred. range - 3 mos $3.07 - $3.07 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Dec 08, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Sep 26, 2025 - 52 days
Short MA 3 mos Buy Low Sep 15, 2025 - 61 days
Long MA 3 mos Buy Medium Oct 23, 2025 - 33 days
Short/Long MA 3 mos Buy Medium Oct 23, 2025 - 33 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 40.16
Signal Type Signal Value Importance Data
Trend - 12 mos 22.75 % Very High Width: 1,126.22 %
Pred. range - 12 mos $0.741 - $9.08 High -75.87 % - 195.86 %
Short MA 12 mos Buy Very High Oct 03, 2025 - 47 days
Long MA 12 mos Sell Very High Sep 05, 2025 - 67 days
Short/Long MA 12 mos Sell Very High Sep 26, 2025 - 52 days
Pivot Long Sell Low Dec 08, 2025 - 2 days
RSI Long Pivot Signal Sell Low Oct 07, 2025 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT MEI PHARMA
MEI Pharma
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cycl...
GOLDEN STAR
Ticker Change Signal Date
NESR
$25.06
0.439% Jun 22
IDYA
$28.98
25.19% Jun 12
PHM
$118.49
14.53% Jun 10
DHI
$146.71
13.50% Jun 10
EAT
$140.46
20.94% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE